Related Experiment Video
Updated: Jun 28, 2025
02:09
Multi-modal Pulmonary Imaging: Using Complementary Information from CT and Hyperpolarized 129Xe MRI to Evaluate Lung Structure-Function
Published on: April 12, 2024
585
Exploratory Study on COPD Phenotypes and their Progression: Integrating SPECT and qCT Imaging Analysis
Frank Li1,2, Xuan Zhang3,2, Alejandro P Comellas4
1Roy J. Carver Department of Biomedical Engineering, University of Iowa, Iowa City, Iowa, USA.
Medrxiv : the Preprint Server for Health Sciences
|April 22, 2024
Summary
Ventilation heterogeneity in chronic obstructive pulmonary disease (COPD) is linked to small airway disease. Maximum tracer concentration (TCmax) better predicts COPD progression than ventilation heterogeneity (CVTotal).
Area of Science:
- Pulmonary Medicine
- Radiology
- Medical Imaging
Background:
- Investigating chronic obstructive pulmonary disease (COPD) phenotypes and progression requires understanding lung ventilation heterogeneity.
- Quantitative computed tomography (qCT) and single photon emission computed tomography (SPECT) imaging offer complementary insights into COPD structural and functional changes.
Approach:
- A longitudinal study quantified lung ventilation heterogeneity using SPECT and correlated these findings with qCT-derived structural and functional variables in eight COPD patients over two years.
- SPECT-derived ventilation heterogeneity metrics (CVTotal, TCmax) were analyzed against qCT measures (fSAD%Total, Emph%Total) and airway characteristics.
Key Points:
- SPECT-derived ventilation heterogeneity (CVTotal) strongly correlated with qCT measures of small airway disease (fSAD%Total) and emphysema (Emph%Total) in cross-sectional analysis.
- Over two years, SPECT's maximum tracer concentration (TCmax) showed strong negative correlations with fSAD%Total and Emph%Total, indicating its sensitivity to disease progression.
- Airway narrowing and lobar ventilation imbalance contribute to ventilation abnormalities (hot spots) in COPD.
Conclusions:
- Small airway disease is a primary driver of ventilation heterogeneity in COPD.
- Maximum tracer concentration (TCmax) serves as a more sensitive functional biomarker for COPD progression compared to the coefficient of variation (CVTotal).
- Understanding these imaging-based correlations aids in characterizing COPD phenotypes and tracking disease advancement.
More Related Videos
Related Concept Videos
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
01:20COPD: Pathogenesis and Clinical Features
267
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
267
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
01:22Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K
01:26COPD: Management Using Bronchodilators and Corticosteroids
198
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
198